Plozasiran: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Plozasiran. Educational only — not medical advice.
Labeled uses
REDEMPLO is indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS).
Source: FDA labeling via NIH DailyMed (set 7fd37993…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.